Dark Forest Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Dark Forest Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,940	Closed	-$81.9K	–	1105
2023 Q1	$81.9K	Buy	+4,940	New	+$81.5K	0.02%	720
2022 Q3	–	Sell	-3	Closed	–	–	1183
2022 Q2	$0	Sell	3 -37,730	-100%	-$277K	﹤0.01%	966
2022 Q1	$313K	Buy	+37,733	New	+$267K	0.07%	297

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dark Forest Capital Management's CPRX Position: Q2 2023 in Review

Dark Forest Capital Management sold out of Catalyst Pharmaceutical (CPRX) in Q2 2023, closing a stake of 4,940 shares — an estimated $81.9K sold.

Dark Forest Capital Management first reported a position in CPRX in Q1 2022 and held it in 3 quarters. The position peaked at $313K in Q1 2022. 248 funds tracked by Wall St. Rank hold CPRX as of Q2 2023.

Dark Forest Capital Management reported no remaining Catalyst Pharmaceutical position as of Q2 2023 after selling out during the quarter.
Dark Forest Capital Management sold 4,940 Catalyst Pharmaceutical shares in Q2 2023, an estimated $81.9K.
Dark Forest Capital Management first reported a position in Catalyst Pharmaceutical in Q1 2022 and held it in 3 quarters.
Dark Forest Capital Management's Catalyst Pharmaceutical position peaked at $313K in Q1 2022.
248 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.